Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Dalamaga

Showing results (191-200 of 261) with videos related to

Pageof 27
Sort By:
Genetic Testing and Molecular Biomarkers|October 27, 2010
The association between a common FCGR2A polymorphism and C-reactive protein and coronary artery disease revisitedChristos Kroupis, Maria Theodorou, Antigoni Chaidaroglou, et al.
Endocrine|February 19, 2018
Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factorsTheodora Stratigou, Maria Dalamaga, Georgios Antonakos, et al.
Current Nutrition Reports|August 6, 2022
Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future PerspectivesDimitris Kounatidis, Natalia G Vallianou, Dimitrios Tsilingiris, et al.
International Journal of Molecular Sciences|April 13, 2023
The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future PerspectivesNatalia G Vallianou, Dimitris Kounatidis, Dimitrios Tsilingiris, et al.
Maturitas|August 16, 2011
Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stressKonstantinos Kazanis, Maria Dalamaga, Eva Kassi, et al.
Diabetes/Metabolism Research and Reviews|July 1, 2023
Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndromeIoannis G Lempesis, Samuel J Apple, Gustavo Duarte, et al.
Biomolecules|June 26, 2026
Revisiting the Lipid-Cancer Axis: PCSK9, ANGPTL3, and CETP as Emerging Biomarkers and Therapeutic Targets in OncologyDimitris C Kounatidis, Natalia G Vallianou, Fotis Panagopoulos, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 16, 2015
Circulating resistin is a significant predictor of mortality independently from cardiovascular comorbidities in elderly, non-diabetic subjects with chronic kidney diseaseAnna Marouga, Maria Dalamaga, Anastasia N Kastania, et al.
Clinical Laboratory|November 27, 2013
Correlates of serum resistin in elderly, non-diabetic patients with chronic kidney diseaseAnna Marouga, Maria Dalamaga, Anastasia N Kastania, et al.
Medicina (Kaunas, Lithuania)|October 29, 2025
Hormonal Alterations in Individuals with Obesity After Metabolic Bariatric Surgery: A Narrative ReviewIoanna A Anastasiou, Dimitris Kounatidis, Eleni Rebelos, et al.
Pageof 27

Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
Genetic Testing and Molecular Biomarkers|October 27, 2010
The association between a common FCGR2A polymorphism and C-reactive protein and coronary artery disease revisitedChristos Kroupis, Maria Theodorou, Antigoni Chaidaroglou, et al.
Endocrine|February 19, 2018
Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factorsTheodora Stratigou, Maria Dalamaga, Georgios Antonakos, et al.
Current Nutrition Reports|August 6, 2022
Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future PerspectivesDimitris Kounatidis, Natalia G Vallianou, Dimitrios Tsilingiris, et al.
International Journal of Molecular Sciences|April 13, 2023
The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future PerspectivesNatalia G Vallianou, Dimitris Kounatidis, Dimitrios Tsilingiris, et al.
Maturitas|August 16, 2011
Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stressKonstantinos Kazanis, Maria Dalamaga, Eva Kassi, et al.
Diabetes/Metabolism Research and Reviews|July 1, 2023
Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndromeIoannis G Lempesis, Samuel J Apple, Gustavo Duarte, et al.
Biomolecules|June 26, 2026
Revisiting the Lipid-Cancer Axis: PCSK9, ANGPTL3, and CETP as Emerging Biomarkers and Therapeutic Targets in OncologyDimitris C Kounatidis, Natalia G Vallianou, Fotis Panagopoulos, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 16, 2015
Circulating resistin is a significant predictor of mortality independently from cardiovascular comorbidities in elderly, non-diabetic subjects with chronic kidney diseaseAnna Marouga, Maria Dalamaga, Anastasia N Kastania, et al.
Clinical Laboratory|November 27, 2013
Correlates of serum resistin in elderly, non-diabetic patients with chronic kidney diseaseAnna Marouga, Maria Dalamaga, Anastasia N Kastania, et al.
Medicina (Kaunas, Lithuania)|October 29, 2025
Hormonal Alterations in Individuals with Obesity After Metabolic Bariatric Surgery: A Narrative ReviewIoanna A Anastasiou, Dimitris Kounatidis, Eleni Rebelos, et al.
Pageof 27